Anna Plym

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Polygenic risk score and 20-year prostate cancer-specific mortality and survival.

Polygenic risk score and 20-year prostate cancer-specific mortality and survival.

Journal: Communications medicine

Published: October 27, 2025

A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum.

A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum.

Journal: The Journal of urology

Published: July 08, 2025

A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial.

A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial.

Journal: The Journal of urology

Published: April 09, 2025

Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors.

Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors.

Journal: European urology oncology

Published: January 09, 2025

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.

Journal: Nature cancer

Published: December 04, 2024

Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.

Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 22, 2024

Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk.

Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk.

Journal: JAMA network open

Published: July 03, 2024

Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.

Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.

Journal: The Journal of urology

Published: April 10, 2024

Healthy lifestyle and prostate cancer risk in the Million Veteran Program.

Healthy lifestyle and prostate cancer risk in the Million Veteran Program.

Journal: Cancer

Published: January 27, 2024

Combining magnetic resonance imaging with a multi-ancestry polygenic risk score to improve identification of clinically significant prostate cancer.

Combining magnetic resonance imaging with a multi-ancestry polygenic risk score to improve identification of clinically significant prostate cancer.

Journal: JNCI cancer spectrum

Published: December 12, 2023

Healthy dietary patterns and risk of prostate cancer in men at high genetic risk.

Healthy dietary patterns and risk of prostate cancer in men at high genetic risk.

Journal: International journal of cancer

Published: November 28, 2023

Agent orange exposure and prostate cancer risk in the million veteran program.

Agent orange exposure and prostate cancer risk in the million veteran program.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 04, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026